KRAS and cancer: Whether or not the GEM models recapitulate human cancers is not clear, but oncogenic signaling is regulated similarly between mouse models and human cancer according to mRNA profiling analysis, as shown by Sweet-Cordeo et al. A comparison of a mouse lung cancer model with K-ras mutations and human lung cancer with KRAS mutations revealed that mouse signature genes were also consistently regulated in humans [29].